지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
이용수
초록· 키워드
오류제보하기
Purpose: To compare, with the use of chest radiographic findings, improvement and complications in newborns treated with exogenous surfactant for hyaline membrane disease (HMD), and an untreated control group. Materials and Methods: Thirty-six patients with HMD were randomly assigned to a control group (n=18) or surfactant treated group (n=18). As part of an initial evaluation of their pulmonary status, we then performed a retrospective statistical analysis of chest radiographic findings obtained in exogenous surfactant treated and untreated infants within the first 90 minutes of life. Subsequent examinations were performed at less than 24hours of age. Results: Chest radiograph before treatment showed to significant differences between the two groups, but significant improvement was noted in the surfactant treated group, in contrast to the control group. The most common chest radiographic finding after surfactant administration was uniform (n=15) or disproportionate (n=2) improvement of pulmonary aeration. Patent ductus arteriosus developed in three treated neonates and in four cases in the control group. Air leak occurred in three cases in the treated group and in five cases in the control group. In one treated patient pulmonary hemorrhage developed and intracranial hemorrhage occurred in three treated neonates and in four cases in the control group. Bronchopulmonary dysplasia was developed in 6 cases of treated group and 3 cases of control group. Conclusion: A chest radiograph is considered to be helpful in the evaluation of improvement and complications of HMD in infants treated with surfactant.
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
신생아 호흡곤란증 치료를 위한 새로운 합성 표면활성제
Neonatal medicine
2012 .01
-
Surfactant preparations for preterm infants with respiratory distress syndrome: past, present, and future
Clinical and Experimental Pediatrics
2019 .01
-
성인성 호흡곤란 증후군에 있어서 Surfactant 치료
Tuberculosis and Respiratory Diseases
1993 .01
-
중증 태변 흡인 증후군에서 폐표면 활성제 치료
Neonatal medicine
2013 .01
-
신생아 호흡 곤란 증후군에서 CurosurfⓇ와 NewfactanⓇ의 치료 효과 비교
Neonatal medicine
2008 .01
-
Surfactant-Associated Proteins의 유전인자 발현
Tuberculosis and Respiratory Diseases
1991 .01
-
태변흡인증후군에서 폐표면활성제 사용이 호흡기지표에 미치는 영향에 대한 체계적 문헌고찰과 메타분석
Neonatal medicine
2011 .01
-
인터루킨-1α를 기관지 투입 후 나타난 폐세척액에서의 대식세포의 미세구조적 변화
대한의생명과학회지
1996 .12
-
기관내 내독소 투여로 유도한 백서의 급성 폐손상 모델에서 surfactant가 호중구의 아포토시스에 미치는 영향
Tuberculosis and Respiratory Diseases
2002 .01
-
Efficacy of Surfactant-TA, Calfactant and Poractant Alfa for Preterm Infants with Respiratory Distress Syndrome: A Retrospective Study
Yonsei Medical Journal
2015 .01
-
한국 신생아의 폐 표면 활성제 단백-A2(Human Surfactant Protein-A2) 유전자 대립형질의 분포와 빈도
Clinical and Experimental Pediatrics
2003 .01
-
한국 신생아의 폐 표면 활성제 단백-A1 (Human Surfactant Protein-A1) 유전자 대립형질의 분포와 빈도
Clinical and Experimental Pediatrics
2002 .01
-
Experimental study on Cervi Cornu on Adjuvant Arthritis in rats
Journal of Pharmacopuncture
2002 .01
-
일산화탄소중독(一酸化炭素中毒)이 가토(家兎) 폐포표면활성물질(肺胞表面活性物質)에 미치는 영향(影響)
대한생리학회지
1972 .01
-
Lung Ultrasonography for the Diagnosis of Respiratory Distress Syndrome in Late Preterm Infants: Changing Incidence – A Single Center Experience
Neonatal medicine
2017 .01
-
Genetic risk factors associated with respiratory distress syndrome
Clinical and Experimental Pediatrics
2014 .01
-
내독소 및 Thiourea 투여 후 Surfactant protein B와 C 유전자 발현의 비교 관찰
Tuberculosis and Respiratory Diseases
2003 .01
-
Comparison of Outcomes between Prophylactic and Rescue Therapy of Surfactant in Premature Infants
Neonatal medicine
2013 .01
-
Tumor Necrosis Factor가 Surfactant Protein A, B, C의 유전자 발현에 미치는 영향에 관한 실험적 연구
Tuberculosis and Respiratory Diseases
2000 .01
-
Effects of Raphani Semen on Immuno-response in the Mouse Model of allergi Asthma
Journal of Pharmacopuncture
2002 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0